DBD Stock Overview
Manufactures and trades in pharmaceuticals and medical equipment in Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for DBD from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫59,800.00 |
| 52 Week High | ₫60,500.00 |
| 52 Week Low | ₫39,000.00 |
| Beta | 0.067 |
| 1 Month Change | 26.43% |
| 3 Month Change | 40.21% |
| 1 Year Change | 38.43% |
| 3 Year Change | 88.69% |
| 5 Year Change | 95.77% |
| Change since IPO | 122.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| DBD | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 5.5% | 2.1% | -0.4% |
| 1Y | 38.4% | 35.7% | 11.9% |
Return vs Industry: DBD exceeded the VN Pharmaceuticals industry which returned 35.7% over the past year.
Return vs Market: DBD exceeded the VN Market which returned 11.9% over the past year.
Price Volatility
| DBD volatility | |
|---|---|
| DBD Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in VN Market | 6.8% |
| 10% least volatile stocks in VN Market | 2.0% |
Stable Share Price: DBD has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DBD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,343 | Huong Thi Pham | www.bidiphar.com |
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary; analgesic and antipyretic drugs; anti-inflammatory analgesic drugs; drugs for muscle, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous system drugs for brain circulation improvement; vitamins and minerals; endocrine hormones; respiratory drugs; antifungal and antiviral drugs; dermatologic drugs; antidote; drugs for treating lipid disorders; and supplements. The company also offers automatic medicine cooker, water distillers, distilled water tanks, hand sanitizer washbasin, medical solid waste incinerators, washing machines, eye drop bottle washer, clothes dryer, autoclave machines, and drying and climate cabinets.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Fundamentals Summary
| DBD fundamental statistics | |
|---|---|
| Market cap | ₫5.59t |
| Earnings (TTM) | ₫235.82b |
| Revenue (TTM) | ₫1.69t |
23.7x
P/E Ratio3.3x
P/S RatioIs DBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DBD income statement (TTM) | |
|---|---|
| Revenue | ₫1.69t |
| Cost of Revenue | ₫875.78b |
| Gross Profit | ₫818.36b |
| Other Expenses | ₫582.54b |
| Earnings | ₫235.82b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.52k |
| Gross Margin | 48.31% |
| Net Profit Margin | 13.92% |
| Debt/Equity Ratio | 2.9% |
How did DBD perform over the long term?
See historical performance and comparisonDividends
2.7%
Current Dividend Yield59%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 00:33 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luong Lý Nguyen | SSI Securities Corporation |
| Minh Dang | SSI Securities Corporation |
| Quan Cao | Viet Dragon Securities Corporation |